They observed that both intratumor CD4+ and CD8+ T cells of type B3 thymomas and TCs showed higher anti-tumor activity, assessed as cytokine production upon PMA/ionomycin stimulation, compared with the other thymoma subtypes. The gene discussed is CD4; the disease is neoplasm.